Xtract Solutions
Xtract Solutions combines over a decade of software development with the industry-leading outsourcing of Edge Pharma to create a complete allergy immunotherapy management system. At XTRACT we believe that safe and effective immunotherapy begins with the tools necessary to manage the entire clinic, from the time the patient walks in, through the diagnostic process, immunotherapy vial creation, and injections. A key component of this is compliance with the new USP 797 regulations for allergenic extract compounding.
Xtract Immunotherapy Software is designed to address critical safety issues, and specifically to prevent incorrect injections. It is not a EMR program that has been altered to fit the allergy space. Instead, it is software that was developed for allergy practices, and interfaces with EMRs used in physician offices. It allows clinics that are still using paper charts to phase out that process because Xtract’s software displays the patients’ complete history in an easy to view, customizable format [ more…]
Why XTRACT Software?
Increased productivity for the doctor, nurse, and pharmacy technician.
Patient Safety Improvement
The software barcode scans the vial to make sure it is correct and what the next dose should be.
Waiting Room Improvements
Login kiosk software alerts the nurse and adds the patient to the queue. Our waiting room monitor tells the patient how much time they have left before they can leave.
Improved Patient Adherence
Our reminders are texted to patients three days before immunotherapy appointments, helping with patient compliance.
Interface with EMR
All workflows done in one place with a single user login.
Reports & Data Analytics
Reporting features and data analytics - When clients are tracking important information on paper or Excel you have no way to run a report on that data. With Xtract you can.
Latest Posts
Food Allergies in Children and Adults
There was a 50% increase in food allergy in children between the years 1997 and 2011, according to the Centers for Disease Control. The increase
Allergen Treatment Set Labeling
SCIT is considered safe, although adverse reactions to allergen immunotherapy do occur. Clear and consistent labeling helps prevent errors and is a critical component of SCIT safety.
Resuming SCIT during COVID-19
The COVID-19 pandemic has caused a disruption in subcutaneous therapy (SCIT). Now practices are considering the best way to re-engage allergy immunotherapy patients.